Experimental Drug Targets Hypoglycemia-Induced Retinal Damage in Diabetic Retinopathy

Researchers identify HIF protein as a key driver of blood-retinal barrier breakdown in diabetic mice and propose clinical trials for HIF inhibitor 32-134D.